STOCK TITAN

Alector reprices employee options to $1.87

Early exercise before the retention period ends requires employees to pay the option’s original exercise price.

(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
8-K

Rhea-AI Filing Summary

Alector, Inc. approved an option repricing effective October 13, 2026, setting the exercise price for eligible options at $1.87 per share. It generally covered options granted to current employees under the 2019 Equity Incentive Plan or 2017 Stock Option and Grant Plan, held by continuing employees and priced above $1.87. Approximately 4.05 million shares underlie all repriced options. These include options for 2,421,197 shares held by Arnon Rosenthal, Ph.D., Co-founder and Chief Executive Officer (original exercise prices of $6.48–$23.70), and 87,385 shares held by Grace Wong-Sarad, Chief Accounting Officer and principal accounting officer (original exercise prices of $9.46–$23.70).

An employee exercising a repriced option before the Retention Period ends must pay its original exercise price. The period ends at the earliest of one year after the effective date, a Change in Control, or the option holder’s death or Disability. The repricing does not change option expiration dates, service-based vesting criteria, or the number of underlying shares.

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance
Key personnel changes including departures, elections, or appointments of directors and executive officers.
New exercise price $1.87 per share For repriced options, effective October 13, 2026
Shares underlying all repriced options Approximately 4.05 million shares As of the October 13, 2026 effective date
Options held by Arnon Rosenthal 2,421,197 shares Original exercise prices ranged from $6.48 to $23.70 per share
Options held by Grace Wong-Sarad 87,385 shares Original exercise prices ranged from $9.46 to $23.70 per share
Original exercise price range $6.48 to $33.11 per share All repriced options
Retention Period One year One possible end point is one year after October 13, 2026; the period may end earlier upon a Change in Control or the option holder’s death or Disability
Eligible Options financial
"had an exercise price per share greater than $1.87"
premium exercise price financial
"required to pay a premium exercise price"
Retention Period financial
"begins on the effective date of the repricing"
underwater financial
"a majority of stock options held by Company employees were “underwater,”"
service-based vesting criteria financial
"no change to the expiration dates or service-based vesting criteria"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many shares are covered by ALEC’s option repricing?

Approximately 4.05 million shares underlie all repriced options.

What is the new exercise price for repriced ALEC options?

The new exercise price is $1.87 per share.

Why did Alector reprice employee options?

The Board said it designed the repricing, including the Retention Period, to retain and motivate holders of Eligible Options to continue working in the best interests of Alector and its stockholders.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
false000165308700016530872026-10-132026-10-13

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): October 13, 2026

 

 

Alector, Inc.

(Exact name of Registrant as Specified in Its Charter)

 

 

Delaware

001-38792

82-2933343

(State or Other Jurisdiction
of Incorporation)

(Commission File Number)

(IRS Employer
Identification No.)

 

 

 

 

 

131 Oyster Point Blvd.

Suite 600

 

South San Francisco, California

 

94080

(Address of Principal Executive Offices)

 

(Zip Code)

 

Registrant’s Telephone Number, Including Area Code: (415) 231-5660

 

 

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of each class

 

Trading
Symbol(s)

 


Name of each exchange on which registered

Common Stock

 

ALEC

 

The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 


Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

(e) Option Repricing

On October 13, 2026 (the “Effective Date”), the Board of Directors (the “Board”) of Alector, Inc. (“Alector” or the “Company”) approved an option repricing. The repricing generally applied to stock options to purchase shares of the common stock of Alector that: (i) were granted to current employees under the Company’s 2019 Equity Incentive Plan, as amended (the “2019 Plan”), or the Company’s 2017 Stock Option and Grant Plan (together with the 2019 Plan, the “Plans”) and applicable award agreements thereunder; (ii) as of the effective date of the repricing, were held by continuing employees; and (iii) had an exercise price per share greater than $1.87 (the “Eligible Options”).

The repriced options include Eligible Options held by each of Arnon Rosenthal, Ph.D., the Company’s Co-founder and Chief Executive Officer (options to purchase an aggregate of 2,421,197 shares with original exercise prices ranging from $6.48 to $23.70 per share) and Grace Wong-Sarad, the Company’s Chief Accounting Officer and principal accounting officer (options to purchase an aggregate of 87,385 shares with original exercise prices ranging from $9.46 to $23.70 per share).

The new exercise price for repriced options is $1.87 per share, the closing price of the Company’s common stock on the Effective Date. However, if an employee exercises a repriced Eligible Option before the end of the Retention Period (as defined below), such employee will be required to pay a premium exercise price that is equal to the original exercise price per share of such Eligible Option as in effect immediately prior to the Effective Date. There was no change to the expiration dates or service-based vesting criteria of, or number of shares underlying the Eligible Options, and such options remain subject to the terms of the applicable Plans and award agreements. For the purposes of the repricing, “Retention Period” means the period that begins on the effective date of the repricing and ends on the earliest of the following: (i) one year following the Effective Date; (ii) a Change in Control (as defined in the applicable Plan); and (iii) the option holder’s death or Disability (as defined in the applicable Plan).

The Board approved the repricing following careful consideration of various alternatives and a review of other applicable factors, receipt of the advice of the Company’s independent compensation consultant and recommendation of the People, Culture, and Compensation Committee of the Board, with deliberations relating to the repricing occurring throughout 2026. The Board designed the repricing, including the provision of the Retention Period, with the objectives of retaining and motivating the holders of the Eligible Options to continue to work in the best interests of the Company and its stockholders. By implementing the repricing, the Company would not be incurring the stock dilution resulting from additional equity grants or additional cash expenditures resulting from additional cash compensation that could have been considered as alternatives for retention and motivation as compared to a repricing. As of the date of approval of the repricing, a majority of the stock options held by Company employees were “underwater,” with exercise prices per share above the current market price of a share of the Company’s common stock. The total number of shares underlying all repriced options was approximately 4.05 million shares. The repriced options previously had exercise prices ranging from $6.48 to $33.11 per share.

 

 


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

ALECTOR, INC.

 

 

 

 

Date:

October 14, 2026

By:

/s/ Arnon Rosenthal

 

 

 

Arnon Rosenthal, Ph.D.
Co-founder and Chief Executive Officer

 


Filing Exhibits & Attachments

1 document

Keep reading